Education
About Us
Working with TipRanks
Follow Us
Hologic (HOLX)
NASDAQ:HOLX
HOLX Stock Chart & Stats
$74.15
$0.05(0.07%)
At close: 4:00 PM EST
$74.15
$0.05(0.07%)
Day’s Range― - ―
52-Week Range$51.90 - $80.31
Previous CloseN/A
Volume386.02K
Average Volume (3M)3.99M
Market Cap
$16.50B
Enterprise Value$15.48B
Total Cash (Recent Filing)$1.88B
Total Debt (Recent Filing)$2.52B
Price to Earnings (P/E)29.9
Beta>-0.01
Next Earnings
Feb 04, 2026EPS Estimate
1.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.13
Shares Outstanding222,566,510
10 Day Avg. Volume3,448,718
30 Day Avg. Volume3,988,949
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)3.74
Price to Sales (P/S)4.76
P/FCF Ratio16.77
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue3.83
Enterprise Value/Gross Profit7.41
Enterprise Value/Ebitda14.19
Forecast
1Y Price Target
$79.30Price Target Upside6.95% Upside
Rating ConsensusHold
Number of Analyst Covering13
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Acquisition AgreementHologic announced a definitive agreement to be acquired by funds managed by Blackstone and TPG in a transaction valued at up to $79 per share, providing a substantial premium to shareholders.
Product Launch ImpactThe launch of Hologic's next-generation mammography system, Envision, is expected to provide a multi-year tailwind to revenue and earnings growth starting in mid-2026.
Revenue GrowthHologic's revenue of $1.05 billion was up 5.4% organically year-over-year, outperforming consensus estimates and indicating a positive growth trajectory.
Bears Say
Deal Valuation ConcernsThe deal price with the contingent value right is 6% below the 52-week high reached last November, indicating limited immediate upside potential.
Market Performance DowngradeAnalyst downgrades shares to Market Perform as there are better relative upside opportunities elsewhere.
Transaction RisksRisks include the take-private transaction being delayed or not closing, and slower-than-expected growth in Breast Health.
Hologic News
HOLX FAQ
What was Hologic’s price range in the past 12 months?
Hologic lowest stock price was $51.90 and its highest was $80.31 in the past 12 months.
What is Hologic’s market cap?
Hologic’s market cap is $16.50B.
When is Hologic’s upcoming earnings report date?
Hologic’s upcoming earnings report date is Feb 04, 2026 which is in 78 days.
How were Hologic’s earnings last quarter?
Hologic released its earnings results on Oct 21, 2025. The company reported $1.13 earnings per share for the quarter, beating the consensus estimate of $1.098 by $0.032.
Is Hologic overvalued?
According to Wall Street analysts Hologic’s price is currently Undervalued.
Does Hologic pay dividends?
Hologic does not currently pay dividends.
What is Hologic’s EPS estimate?
Hologic’s EPS estimate is 1.09.
How many shares outstanding does Hologic have?
Hologic has 222,566,510 shares outstanding.
What happened to Hologic’s price movement after its last earnings report?
Hologic reported an EPS of $1.13 in its last earnings report, beating expectations of $1.098. Following the earnings report the stock price went down -0.068%.
Which hedge fund is a major shareholder of Hologic?
Currently, no hedge funds are holding shares in HOLX
Hologic Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$79.30 (6.95% Upside)
$79.30 (6.95% Upside)
Blogger Sentiment
Bullish
HOLX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 991.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.9%
Last 30 Days ▲ 15.9%
Last 30 Days ▲ 15.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-4.37%
12-Months-Change
Fundamentals
Return on Equity
11.12%
Trailing 12-Months
Asset Growth
-1.54%
Trailing 12-Months
Company Description
Hologic
Hologic, Inc. is a global medical technology company primarily focused on women's health. Founded in 1985 and headquartered in Marlborough, Massachusetts, Hologic develops, manufactures, and markets a range of diagnostic, surgical, and medical imaging products. The company's core sectors include breast health, diagnostics, gynecological health, and skeletal health, with flagship products such as 3D mammography systems, molecular diagnostics tests, and surgical instruments designed for minimally invasive procedures.
HOLX Company Deck
HOLX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with strong financial performance and promising developments in the Breast Health and Diagnostics segments. Despite some challenges in specific markets and product lines, the company's strategic initiatives and successful product launches indicate a solid path toward growth.View all HOLX earnings summariesHOLX Revenue Breakdown
44.22% Diagnostics
37.79% Breast Health
15.91% GYN Surgical
2.09% Skeletal Health
HOLX Stock 12 Month Forecast
Average Price Target
$79.30
▲(6.95% Upside)
Technical Analysis
Baxter International
―
Becton Dickinson
―
Intuitive Surgical
―
Resmed
―
West Pharmaceutical Services
―
Ownership Overview
1.51% Insiders
31.01% Mutual Funds
7.84% Other Institutional Investors
32.55% Public Companies and
Individual Investors